Company Badge
USPTO Data Jan 1 1976 - Oct 13 2026
5 Patents
#15 in Yantai
#5,255 in China
Remegen Co., Ltd.
Forward Citations = 0
18 inventors:
Remegen Co., Ltd.
CIPO Patents = 3
EPO Patents = 5
Trademarks = 1
Forward Citations = 0
Loading Chart...
Loading Chart...
18 inventors (with patents filed for the assignee):
Jianmin Fang (3 out of 13 patents)
Xuejing Yao (3 out of 6 patents)
Jing Jiang (2 out of 6 patents)
4. Guiping Qi (2 out of 2 patents)
5. Wenlong Sun (2 out of 2 patents)
6. Ling Wang (1 out of 3 patents)
7. Changjiang Huang (1 out of 8 patents)
8. Xuejing Luan (1 out of 1 patent)
9. Wenting Luo (1 out of 4 patents)
10. Hui Ye (1 out of 2 patents)
11. Hu Chen (1 out of 1 patent)
12. Nan Shen (1 out of 1 patent)
13. Xiuzhi Zhan (1 out of 1 patent)
14. Qiaohua Hou (1 out of 1 patent)
15. Shenjun Li (1 out of 1 patent)
5 patents:
Company Overview
Remegen Co., Ltd. is a biopharmaceutical company focused on the research, development, and commercialization of innovative therapies for cancer and autoimmune diseases. Established in 2015, the company is dedicated to advancing the field of medicine through cutting-edge technology and a commitment to improving patient outcomes. Remegen's pipeline includes several promising candidates that leverage monoclonal antibody and antibody-drug conjugate platforms. With a strong emphasis on scientific excellence and collaboration, Remegen aims to address unmet medical needs and contribute to the global fight against serious diseases.
Profile summary synthesized from public USPTO records and patent filings.
IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Remegen Co., Ltd.. Retrieved from https://idiyas.com/company/remegen-company
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
3 patents (CIPO):
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
5 patents (EPO):
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]